niclosamide has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metabolic disorders such as type 2 diabetes, fatty liver disease, hyperlipidemia, and obesity commonly co-occur but clinical treatment options do not effectively target all disorders." | 2.44 | Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice. ( Alexopoulos, SJ; Beretta, M; Byrne, FL; Cantley, J; Chen, SY; Garcia, CJ; Hoehn, KL; Larance, M; Olzomer, EM; Philp, A; Salamoun, JM; Santos, WL; Shah, DP; Smith, GC; Turner, N, 2024) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SY | 1 |
| Beretta, M | 1 |
| Olzomer, EM | 1 |
| Alexopoulos, SJ | 1 |
| Shah, DP | 1 |
| Byrne, FL | 1 |
| Salamoun, JM | 1 |
| Garcia, CJ | 1 |
| Smith, GC | 1 |
| Larance, M | 1 |
| Philp, A | 1 |
| Turner, N | 1 |
| Santos, WL | 1 |
| Cantley, J | 1 |
| Hoehn, KL | 1 |
| Park, JS | 1 |
| Lee, YS | 1 |
| Lee, DH | 1 |
| Bae, SH | 1 |
2 other studies available for niclosamide and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice.
Topics: Animals; Caloric Restriction; Diabetes Mellitus, Type 2; Ethanolamine; Ethanolamines; Female; Mice; | 2024 |
Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Anthelmintics; Antioxidants; Cell Line; Diet, High-Fa | 2019 |